跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 58,846 条关于
“Amyloid-Related Imaging Abnormalities”
全部
58,846
临床试验
45,511
药物
443
机构
154
资讯
12,738
去年
Gantenerumab's ARIA-E Risk Factors Identified in Alzheimer's Trials
去年
Trontinemab Demonstrates Effective Amyloid Removal with Reduced ARIA Risk in Alzheimer's Trial
去年
New Alzheimer's Treatments Slow Disease Progression, Offer Hope for Early-Stage Patients
去年
Advances in Alzheimer's Diagnostics and Therapeutics Highlighted at Recent Conference
2年前
FDA Approves Lilly's Kisunla (donanemab-azbt) for Early Symptomatic Alzheimer's Disease
去年
FDA Recommends Enhanced Brain Monitoring for Alzheimer's Patients on Leqembi Following Six Early Deaths
3年前
Lecanemab Shows Promise in Slowing Cognitive Decline in Early Alzheimer's Disease
去年
European Regulators Reject Eli Lilly's Alzheimer's Drug Kisunla Over Safety Concerns
去年
icometrix's AI-Powered icobrain aria Receives FDA Clearance for ARIA Detection
去年
Enhanced Donanemab Titration Reduces ARIA-E Risk in Alzheimer's Patients
第 1 页,共 1274 页
上一页
下一页